Surgical Management of Skull Base and Spinal Chordomas: A Systematic Review and Meta-Analysis
Head Surgical Management of Skull Base and Spinal Chordomas
DOI:
https://doi.org/10.29409/ggp30h72Keywords:
Chordoma, Adjuvant therapy, skull base, spine, sacrococcygeal, surgeryAbstract
Background: Chordomas are rare tumors originating from residual chordate tissues, predominantly affecting the base of the skull and the axial skeleton. Aim: This systematic review investigates the anatomical aspects and neurosurgical treatment modalities of skull base and spinal chordomas. Methods: We conducted a systematic literature review, adhering to PRISMA guidelines, by searching Databases including PubMed/Medline, Scopus, ScienceDirect, and EBSCO. Data was managed using Microsoft Excel and analysis was performed using SPSS Statistics for Windows, version 26.0 (IBM Corp., Armonk, NY, USA). PROSPERO Registration Number; CRD420261322007. Results: In this study, we conducted a systematic review and meta-analysis, including a total of N=2,083 patients with clinical and neurological manifestations, as outlined between Table I and Table IV. The analysis results are summarized in Table 1. N=1,485, (71.5%) patients, N=636, Gross total resection (GTR), N=640, subtotal resection (STR), N=568, Radiotherapy, as detailed in Tables I and II and Figures 1, 2, and 3. Heterogeneity was assessed as follows: I² = [23%, 24%, 32%]. P = 0.21. Conclusion: The aggressive nature of chordomas necessitates personalized treatment strategies. Surgical approaches, particularly for elderly patients, proved promising in chordoma excision. Despite advancements, further research into disease management and etiopathogenesis is crucial for improved prevention, detection, and treatment strategies. Adjuvant therapies exhibited enhanced survival rates, highlighting their significance in prolonging patients' lives post-surgery.
References
1. Denaro L, Berton A, Ciuffreda M, Loppini M, Candela V, Brandi ML, et al. Surgical management of chordoma: A systematic review. The Journal of Spinal Cord Medicine. 2020 Nov 1;43(6):797–812.
2. Das P, Soni P, Jones J, Habboub G, Barnholtz-Sloan JS, Recinos PF, et al. Descriptive epidemiology of chordomas in the United States. J Neurooncol. 2020 May;148(1):173–8.
3. Cha YJ, Suh YL. Chordomas: Histopathological Study in View of Anatomical Location. J Korean Med Sci. 2019;34(13):e107.
4. Eid AS, Chang UK, Lee SY, Jeon DG. The treatment outcome depending on the extent of resection in skull base and spinal chordomas. Acta Neurochir. 2011 Mar;153(3):509–16.
5. Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 2010 Dec;10(1):22.
6. Kiralj A, Ilic M, Markov B, Dedic S, Pejakovic B, Nalic B. Chondroma of the skull base and maxilla. Med pregl. 2007;60(11–12):649–51.
7. Messerer M, Cossu G, Pasche P, Ikonomidis C, Simon C, Pralong E, et al. Extended endoscopic endonasal approach to clival and paraclival tumors: Indications and limits. Neurochirurgie. 2016 June;62(3):136–45.
8. Vidor I, Sivak-Callcott JA, Rosen CL, Rassekh CH, Williams HJ, Ellis BD. Chordoma of the Anterior Cranial Fossa and Ethmoids with Orbital Involvement. Orbit. 2008 Jan;27(6):444–50.
9. Holzmann D, Reisch R, Krayenbühl N, Hug E, Bernays RL. The Transnasal Transclival Approach for Clivus Chordoma. Minim Invasive Neurosurg. 2010 Oct;53(05/06):211–7.
10. Robles LA, Mundis GM. Chondromas of the Lumbar Spine: A Systematic Review. Global Spine Journal. 2021 Mar;11(2):232–9.
11. Fürtös AM, Sandu AM, Ciubotaru VG, Gorgan RM, Tătăranu LG. Skull base chordomas - emphasis on surgical strategy and recurrence-free survival. Medicine and Pharmacy Reports. 2025 Mar 21;98(2):210–6.
12. Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN. Patient Outcome at Long-term Follow-up after Aggressive Microsurgical Resection of Cranial Base Chordomas. Neurosurgery. 2006 Aug;59(2):230–7.
13. Potluri S, Jefferies SJ, Jena R, Harris F, Burton KE, Prevost AT, et al. Residual Postoperative Tumour Volume Predicts Outcome after High-dose Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine. Clinical Oncology. 2011 Apr;23(3):199–208.
14. Xin Y, Hao S, Zhang J, Wu Z, Jia G, Tang J, et al. Microsurgical treatment of intracranial chondroma. Journal of Clinical Neuroscience. 2011 Aug;18(8):1064–71.
15. Rich TA, Schiller A, Suit HD, Mankin HJ. Clinical and pathologic review of 48 cases of chordoma. Cancer. 1985 July 1;56(1):182–7.
16. Stacchiotti S, Sommer J. Building a global consensus approach to chordoma: a position paper from the medical and patient community. The Lancet Oncology. 2015 Feb;16(2):e71–83.
17. Whelan JS, Davis LE. Osteosarcoma, Chondrosarcoma, and Chordoma. JCO. 2018 Jan 10;36(2):188–93.
18. Yaniv D, Soudry E, Strenov Y, Cohen MA, Mizrachi A. Skull base chordomas review of current treatment paradigms. World j otorhinolaryngol-head neck surg. 2020 June;6(2):125–31.
19. Youn SH, Cho KH, Kim JY, Ha B, Lim YK, Jeong JH, et al. Clinical outcome of proton therapy for patients with chordomas. Radiat Oncol J. 2018 Sept 30;36(3):182–91.
20. Sahyouni R, Goshtasbi K, Mahmoodi A, Chen JW. A historical recount of chordoma. Journal of Neurosurgery: Spine. 2018 Apr;28(4):422–8.
21. Li M, Bai J, Wang S, Zhai Y, Zhang S, Li C, et al. Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients. Front Oncol. 2021 Feb 25;11:548325.
22. Xiong Y, Li M, Niu G, Xu T, Li C, Ma T, et al. Identification of immune subtypes associated with the prognosis in skull base chordoma. acta neuropathol commun. 2025 June 13;13(1):130
23. Wang Y, Peng Z, Wang Y, Fan R, Zhang H, Jiang W. The prognostic significance of different degrees of resection of skull base chordoma. Clin Transl Oncol. 2022 Aug 11;24(12):2441–52.
24. Di Maio S, Kong E, Yip S, Rostomily R. Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets. Surg Neurol Int. 2013;4(1):72.
25. Barber SM, Sadrameli SS, Lee JJ, Fridley JS, Teh BS, Oyelese AA, et al. Chordoma—Current Understanding and Modern Treatment Paradigms. JCM. 2021 Mar 4;10(5):1054.
26. Passer JZ, Alvarez-Breckenridge C, Rhines L, DeMonte F, Tatsui C, Raza SM. Surgical Management of Skull Base and Spine Chordomas. Curr Treat Options in Oncol. 2021 May;22(5):40.
27. Samii A, Gerganov VM, Herold C, Hayashi N, Naka T, Mirzayan MJ, et al. Chordomas of the skull base: surgical management and outcome. JNS. 2007 Aug;107(2):319–24.
28. Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ. The Surgical Management of Sacral Chordomas: Spine. 2009 Nov;34(24):2700–4.
29. Noya C, D’Alessandris QG, Doglietto F, Pallini R, Rigante M, Mattogno PP, et al. Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review. Cancers. 2023 Sept 9;15(18):4493.
30. Zhou Y, Hu B, Wu Z, Cheng H, Dai M, Zhang B. The clinical outcomes for chordomas in the cranial base and spine: A single center experience. Medicine. 2019 June;98(23):e15980.
31. Zileli M, Karakoç HTE. Outcomes of chordomas of the sacrum and mobile spine: Clinical series with average 6-year follow-up. Journal of Craniovertebral Junction and Spine. 2021 Oct;12(4):412–9.
32. Smoll NR, Gautschi OP, Radovanovic I, Schaller K, Weber DC. Incidence and relative survival of chordomas: The standardized mortality ratio and the impact of chordomas on a population. Cancer. 2013 June;119(11):2029–37.
33. Zuckerman SL, Lee SH, Chang GJ, Walsh GL, Mehran RJ, Gokaslan ZL, et al. Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients With Long-Term Follow-Up. Global Spine Journal. 2021 June;11(5):740–50.
34. Ikpeze T, Mesfin A. The top 50 cited articles on chordomas. J Spine Surg. 2018 Mar;4(1):37–44.
35. Meng T, Jin J, Jiang C, Huang R, Yin H, Song D, et al. Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review. Front Oncol. 2019 Feb 1;9:30.
36. Tamura T, Sato T, Kishida Y, Ichikawa M, Oda K, Ito E, et al. OUTCOME OF CLIVAL CHORDOMAS AFTER SKULL BASE SURGERIES WITH MEAN FOLLOW-UP OF 10 YEARS. FJMS. 2015;61(2):131–40.
37. Agner KE, Larkins MC. Comparative overall survival analysis of chordomas of the base of the skull from the Surveillance, Epidemiology, and End Results (SEER) program between 2000 and 2020. Neurosurg Rev. 2024 Sept 25;47(1):683.
38. Bai J, Li M, Xiong Y, Shen Y, Liu C, Zhao P, et al. Endoscopic Endonasal Surgical Strategy for Skull Base Chordomas Based on Tumor Growth Directions: Surgical Outcomes of 167 Patients During 3 Years. Front Oncol. 2021 Sept 22;11:724972.
39. Glancz LJ, Hannan CJ, Vyziotis A, Potter GM, Siripurapu R, Bhalla RK, et al. Surgical management of skull base chordomas and chondrosarcomas: insights from a national cohort study. bmjonc. 2024 July;3(1):e000386.
40. Sallabanda M, Garcia R, Lorenzana L, Santaolalla I, Abarca J, Sallabanda K. Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience. Cureus [Internet]. 2021 Aug 8 [cited 2025 Aug 17]; Available from: https://www.cureus.com/articles/67156-treatment-of-chordomas-and-chondrosarcomas-with-cyberknife-robotic-hypofractionated-radiosurgery-a-single-institution-experience
41. Dastgheyb SS, Dreyfuss AD, LaRiviere MJ, Mohiuddin JJ, Baumann BC, Shabason J, et al. A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas. Advances in Radiation Oncology. 2024 May;9(5):101456.
42. Wolf RJ, Winkler V, Mattke M, Uhl M, Debus J. Intensity-modulated radiotherapy for the management of primary and recurrent chordomas: a retrospective long-term follow-up study. Rep Pract Oncol Radiother. 2023 June 26;28(2):207–16.
43. Chilukuri S, Burela N, Sundar S, Kamath R, Nangia S, Arjunan M, et al. Impact of Dosimetric Compromises on Early Outcomes of Chordomas and Chondrosarcomas Treated With Image-guided Pencil Beam Scanning Proton Beam Therapy. Advances in Radiation Oncology. 2024 Oct;9(10):101582.
44. Lee SH, Kwok KY, Wong SM, Chan CXJ, Wong YT, Tsang ML. Chordoma at the skull base, spine, and sacrum: A pictorial essay. JCIS. 2022 Aug 5;12:44.
45. Guan X, Gao J, Hu J, Hu W, Yang J, Qiu X, et al. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine. Radiat Oncol. 2019 Dec;14(1):206.
46. Shidoh S, Toda M, Kawase T, Nakajima H, Tomita T, Ogawa K, et al. Transoral vs. Endoscopic Endonasal Approach for Clival/Upper Cervical Chordoma. Neurol Med Chir(Tokyo). 2014;54(12):991–8.
47. Maioli M, Cocchi S, Gambarotti M, Benini S, Magagnoli G, Gamberi G, et al. Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in SMARCB1 Gene, and Clinicopathological Features in 89 Patients. Cancers. 2024 Aug 9;16(16):2808.
48. Akmansu M, Kurt G, Demircan V, Senturk E. Results of chordoma patients treated by different approaches in a single institution. Turkish Neurosurgery [Internet]. 2019 [cited 2025 Aug 17]; Available from: http://www.turkishneurosurgery.org.tr/summary_en_doi.php3?doi=10.5137/1019-5149.JTN.24406-19.4
49. Aguiar Júnior S, Andrade WP, Baiocchi G, Guimarães GC, Cunha IW, Estrada DA, et al. Natural history and surgical treatment of chordoma: a retrospective cohort study. Sao Paulo Med J. 2014;132(5):297–302.
50. Baig Mirza A, Ravindran V, Okasha M, Boardman TM, Maratos E, Sinan B, et al. Systematic Review Comparing Open versus Endoscopic Surgery in Clival Chordomas and a 10-Year Single-Center Experience. J Neurol Surg B Skull Base. 2022 June;83(S 02):e113–25.
51. Shakil H, Malhotra AK, Essa A, Landry AP, Suppiah S, Sahgal A, et al. Chordoma incidence, treatment, and survival in the 21st century: a population-based Ontario cohort study. Journal of Neurosurgery. 2025 Mar 1;142(3):702–11.
52. Encarnación Santos D, Chmutin G, Chaurasia B. Skull base-cranio-facial trauma with dura mater repair after subsequent CSF leaking, diagnosis treatment and outcomes: A systematic review of the literature. roneuro. 2024 Sept 15;317–27.
53. Encarnacion-Santos D, Bozkurt I, Chmutin G, Chmutin E, Pashev M, Chaurasia B, et al. Analysis of surgical and therapeutic interventions in patients with craniopharyngioma undergoing open transcranial resections versus endoscopic endonasal resections: A systematic review. Annals of Oncology Research and Therapy. 2025 July;5(2):103–13.
54. Encarnación Santos D, Scalia G, Bozkurt I, Volovish A, Tapia Sierra A, Wellington J, et al. Current insights and surgical interventions in craniovertebral junction instability: A systematic review and meta-analysis. roneuro. 2024 June 15;180–8.
55. Zhang Q, Xu Z, Han R, Wang Y, Ye Z, Zhu J, et al. Proteogenomic characterization of skull-base chordoma. Nat Commun. 2024 Sept 27;15(1):8338.
56. Chen G, Li M, Xu W, Wang X, Feng M, Wang R, et al. Surgical Outcomes of Clival Chordoma Through Endoscopic Endonasal Approach: A Single-Center Experience. Front Endocrinol. 2022 Apr 6;13:800923.
57. Fürtös AM, Sandu AM, Ciubotaru VG, Gorgan RM, Tătăranu LG. Skull base chordomas - emphasis on surgical strategy and recurrence-free survival. Medicine and Pharmacy Reports. 2025 Mar 21;98(2):210–6.
Additional Files
Received
Revised
Accepted
Published
Data Availability Statement
Author made data available by reasonable request or citation
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Cancer and Medical Genetics
This work is licensed under a Creative Commons Attribution 4.0 International License.
